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We describe a large consanguineous pedigree from a remote area of Northern Pakistan, with a complex developmental disorder
associated with wide-ranging symptoms, including mental retardation, speech and language impairment and other neurological,
psychiatric, skeletal and cardiac abnormalities. We initially carried out a genetic study using the HumanCytoSNP-12 v2.1 Illumina
gene chip on nine family members and identified a single region of homozygosity shared amongst four affected individuals on
chromosome 7p22 (positions 3059377–5478971). We performed whole-exome sequencing on two affected individuals from two
separate branches of the extended pedigree and identified a novel nonsynonymous homozygous mutation in exon 9 of the WIPI2
(WD-repeat protein interacting with phosphoinositide 2) gene at position 5265458 (c.G745A;pV249M). WIPI2 plays a critical role
in autophagy, an evolutionary conserved cellular pathway implicated in a growing number of medical conditions. The mutation is
situated in a highly conserved and critically important region of WIPI2, responsible for binding PI(3)P and PI(3,5)P2, an essential
requirement for autophagy to proceed. The mutation is absent in all public databases, is predicted to be damaging and segregates
with the disease phenotype. We performed functional studies in vitro to determine the potential effects of the mutation on
downstream pathways leading to autophagosome assembly. Binding of the V231M mutant of WIPI2b to ATG16L1 (as well as
ATG5–12) is significantly reduced in GFP pull-down experiments, and fibroblasts derived from the patients show reduced WIPI2
puncta, reduced LC3 lipidation and reduced autophagic flux.
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Introduction
Autophagy, a self-eating cellular pathway capable of en-
gulfing cytoplasmic contents, is triggered under various
conditions, including oxidative stress, starvation, microbial
infections, or accumulation of misfolded proteins
(Giordano et al., 2013; Green and Levine, 2014; Hurley
and Schulman, 2014; Stepp et al., 2014; Yu et al., 2018).
In particular, its role in various clinical conditions has at-
tracted interest as a possible therapeutic target for cancer
and neurodegenerative conditions, including Huntington’s
disease (Choi et al., 2013; Nixon, 2013; Ebrahimi-
Fakhari et al., 2016).
This cellular pathway leading to autophagy is highly con-
served with more than 40 autophagy related genes (ATG)
in yeast, of which about half are conserved in humans.
Initiation of autophagy begins with the formation of an
autophagosome, which delivers material to the lysosome.
WIPI2, the mammalian homologue of the yeast ATG18
gene, plays a key role in autophagy. It binds the omega-
some, a phosphatidylinositol 3-phosphate [PI(3)P] rich
domain of the endoplasmic reticulum from which the
mature autophagosome develops (Axe et al, 2008; Polson
et al, 2010). Through its interaction with ATG16L1,
WIPI2b recruits the ATG12–5–16L1 complex to the pha-
gophore and therefore enables LC3 lipidation at this site
and subsequent autophagosome formation (Dooley et al.,
2015). LC3 belongs to the ATG8 family of small ubiquitin-
like proteins, which become lipidated on the surface of the
phagophore and autophagosome. Ultimately, the LC3 pro-
teins and other family members are degraded along with
the autophagosome content in the lysosome and then re-
turned to the cytosol. Cells depleted of WIPI2 fail to form
autophagosomes and engulfment of pathogenic bacteria,
including Salmonella, is also severely impaired. Equally,
WIPI2b mutants, unable to bind ATG16L1, inhibit LC3
lipidation and LC3 puncta formation (Dooley et al.,
2014). Site-directed mutagenesis in yeast and crystallization
of the yeast WIPI2 orthologue HSV2 have led to the under-
standing of how the FRRG motif in HSV2 is capable of
binding PI(3)P and phosphatidylinositol 3,5-bisphosphate
[PI(3,5)P2]. Within the FRRG motif, two head groups on
the PI(3)P are bound in site 1 and site 2, located on blades
5 and 6 respectively of the seven-bladed b-propeller struc-
ture (Baskaran et al., 2012; Krick et al., 2012). This mode
of binding is likely to be conserved in WIPI2, which has
been shown to require PI(3)P to bind membranes via the
FRRG motif (Polson et al., 2010).
Evidence linking autophagy to genetic diseases is grow-
ing, especially for neurological conditions (Akizu et al.,
2015; Ebrahimi-Fakhari et al., 2016; Menzies et al.,
2017). Mutations in the familial Parkinson’s disease
genes, PINK1 and parkin (PARK2), involve mitophagy, a
form of autophagy involved in the removal of damaged
mitochondria (Manzanillo et al., 2013; Behr and Schurr,
2013). Genetic variants in the PARK2 gene in humans
and mice deficient in parkin, also show increased suscepti-
bility to intracellular pathogens such as salmonella and
mycobacteria. A common variant in ATG16L1, identified
as a risk factor for Crohn’s disease, is associated with
reduced autophagy (Kaser and Blumberg, 2014; Murthy
et al., 2014), and hemizygous and heterozygous mutations
in WIPI4 have been identified in sporadic patients with
BPAN (b-propeller associated neurodegeneration)—a
neurological condition that is a subtype of NBIA (neurode-
generation with brain iron accumulation), characterized by
childhood onset psychomotor delay, iron deposits in the
brain and patients becoming bedridden (Haack et al.,
2012; Hayflick et al, 2013; Saitsu et al., 2013; Seibler
et al., 2018).
Combining array CGH (comparative genomic hybridiza-
tion) to identify shared regions of homozygosity in affected
family members, with exome sequencing, we previously
identified several disease-causing genes associated with
rare disorders present in consanguineous pedigrees
(Alrayes et al., 2015, 2016; Ahmed et al., 2015;
Mohamoud et al., 2018). Here, we report a novel homo-
zygous recessive mutation in the major autophagy gene,
WIPI2, associated with global developmental abnormalities
in a large consanguineous family (Fig. 1). We show that
WIPI2 V249M mutation results in reduced WIPI2-positive
membranes and a decrease in autophagosome formation
and flux.
Materials and methods
DNA isolation from peripheral blood
The family belonged to a community living in a remote village
in the northern area of Pakistan. Peripheral blood samples
from 10 family members, including both sets of parents,
were collected in K3 EDTA tubes (BD Vacutainer) and
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stored at 4C for genomic DNA isolation and quantification,
using commercially available kits (QIAamp, Qiagen) and a
Nanodrop-2000 spectrophotometer (Thermo Scientific),
respectively.
Ethical consent
Prior to commencement of the study, informed written consent
was obtained from all healthy participants and from the legal
guardians of the affected individuals, including agreement on
publishing the research outcomes. The study was approved,
according to the Declaration of Helsinki, by the Institutional
Review Board (IRB) of the Princess Al-Jawhara Albrahim
Centre of Excellence in Research of Hereditary Disorders
and the Unit of Biomedical Ethics Research Committee (ref.
#24–14), Faculty of Medicine, King Abdulaziz University,
Jeddah, Saudi Arabia.
Study subjects
All the affected and unaffected individuals were initially exam-
ined by clinicians from The Institute of Basic Medical Sciences,
Peshawar, Pakistan and detailed information regarding the dis-
ease history of the affected patients and the pedigree structure
was obtained by interviewing the patients who were then
referred to specialists for detailed cardiac, neurological, ortho-
paedic, psychiatric, psychological, ophthalmic, radiological
and other investigations.
The family tree, shown in Fig. 1, was drawn after interview-
ing the family elders. Four affected, three unaffected, and three
parental samples were available for genetic analysis from two
loops of the pedigree (Fig. 1). Peripheral blood samples from
the 10 available family members were collected in EDTA tubes
and the genomic DNA was extracted using standard methods.
Clinical histories
In addition to the details reported in the results section, other
clinical findings were noted. Dyskinesia and dysarthria are
prominent features. The patients lack in higher instincts such
as self-actualization and self-esteem. Love/belonging and safety
concerns are at minimal. The basic human physiological in-
stincts are intact. Enuresis and nocturia are commonly experi-
enced. Heterogeneity in playful behaviour was noticed among
the patients, with some exhibiting a calm behaviour, while
others having playful attitude. The memory (both short- and
long-term) is impaired. Habituation to oral tobacco (snuff) is
found in one, Patient AA. Primitive sexual desires are
deranged. Reproductive organs have normal morphological
features. Regular nocturnal emissions are reported. The re-
spiratory and gastrointestinal systems do not exhibit any ab-
normal features. Physical examination, radiological assessment
and biochemical findings are suggestive of normal respiratory
and gastrointestinal functions. In Patient NA, the haematolo-
gical indices are suggestive of iron deficiency anaemia. This
corresponded well with his poor socio-economic status and
inadequate hygiene issues.
Homozygosity mapping
To investigate the possible involvement of chromosomal aber-
rations and for the purpose of homozygosity mapping,
HumanCytoSNP-12 v2.1 microarray containing 200 000
single nucleotide polymorphisms (SNPs) throughout the
genome was used together with iScan platform (Illumina) to
Figure 1 Large consanguineous pedigree from Northern Pakistan. Affected members of the family present with a complex develop-
mental disorder affecting multiple tissues segregating as an autosomal recessive condition. Two affected individuals (Patients NA and AA) from
two separate branches of the family were selected for exome sequencing. Cells derived from an unaffected healthy sibling (Subject RG) and an
affected individual (Patient AA) were used in the functional studies. Individuals NA, RG and AA are indicated with arrows. The cG745A mutation
reported in this family was confirmed by Sanger sequencing (Fig. 3) in 10 family members marked with an asterisk. Their corresponding genotypes
(G/G, G/A, A/A) are given.
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analyse all 10 available samples described. The common
region of homozygosity among the affected individuals was
mapped using GenomeStudio data analysis software (Illumina).
Whole-exome sequencing and
analysis
Whole exome paired-end sequencing was performed by
Macrogen starting with 2 mg genomic DNA (260/280 41.7)
by exome capture using the 51Mb SureSelect All Exon V4 kit
(Agilent Technologies) on a HiSeq 2000 platform (Illumina)
generating 50 509146 (Patient AA) and 51 605788 (Patient
NA) reads, yields of 5 101 423746 and 5212 184588 base
pairs, respectively, average read length of 101 bp and read
depth of 99.7 and 101.8, respectively. Ninety-seven per cent
of target regions showed 410 coverage.
For bioinformatic analyses, we used Lasergene Genomic
Suite V.12 software package (DNASTAR, Madison, WI,
USA). Briefly, FASTQ files were aligned to hg19 (NCBI build
GRCh37) using SeqMan NGen 12.2. ArrayStar v.12 was em-
ployed to annotate variant alleles based on dbSNP 142. The
mapped variants were compared with dbSNP (http://www.
ncbi.nlm.nih.gov/snp/) and the 1000 Genomes (http://www.
1000genomes.org/) databases. All homozygous variants,
including single nucleotide variants shared by the two affected
individuals, were filtered using ArrayStar v.12.
Because the family presented with an autosomal recessive
mode of inheritance, we filtered candidate variants using the
following criteria: (i) homozygous or compound heterozygous
in affected individuals, and heterozygous in obligate carriers
for the mutant allele; (ii) present in coding exons; (iii) non-
synonymous, frame-shift, gain/loss of stop codons; (iv) having
a functional effect, e.g. predicted to be pathogenic or deleteri-
ous by in silico prediction software including Provean (Choi
et al., 2012) and MutationTaster2 (Schwarz et al., 2014);
(v) present within the region of homozygosity identified in
SNP microarray genotyping; and (vi) not present in in-house
exome sequence data obtained from 24 normal unrelated
Pakistani individuals.
PCR and gel electrophoresis
WIPI2 forward and reverse primers (50-TTTGAGAAGG
TGGCTAGAGG-30 and 50-ACTGGCTAACGATGTCAGAG-
30, respectively) were designed using Primer 3 software
(Koressaar and Remm, 2007). PCR amplification was per-
formed in a Mastercycler pro Thermal Cycler (Eppendorf)
in a 10 ml reaction volume containing 1ml of genomic DNA
(10–30 ng/ml), 0.1 ml of DreamTaqTM DNA Polymerase
(Thermo Scientific), 1.0ml of 10 DreamTaqTM Green
Buffer (Thermo Scientific), 0.4 ml of a dNTP mix containing
dATP, dTTP, dCTP, and dGTP at a concentration of 5mM
each (Thermo Scientific), 0.4 ml of each primer (Sigma-Aldrich)
at a concentration of 5 pmol, and distilled deionized water.
The reaction conditions were as follows: 95C for 3min, fol-
lowed by 40 cycles at 94C for 30 s, 56C for 30 s, 72C for
30 s, and a final extension at 72C for 7min. PCR products
were separated by electrophoresis in 1.2% agarose gels made
with Tris-acetate-EDTA buffer (Alpha laboratories).
DNA sequencing
The candidate variant was confirmed by Sanger sequencing to
validate the whole exome sequencing data data. Ten available
family members were screened to determine whether or not the
variant in question co-segregated with disease status. PCR
products were purified following the Exonuclease I (New
England Biolabs)–shrimp alkaline phosphatase (Affymetrix)
(ExoSAP) protocol for sequencing reactions. The mixtures
were incubated at 37C for 5 min followed by deactivation
of the ExoSAP reaction at 95C for 5 min.
Sequencing was performed bidirectionally using the BigDye
Terminator Chemistry (Sequenase v3.1 Cycle Sequencing Kit;
Applied Biosystems). The sequencing reactions were performed
in a 10 ml volume containing 1.0 ml of forward or reverse
primer (5 pmol), 2.0 ml of the PCR product, 2.0 ml of 5
BigDye Buffer, 0.5 ml of BigDye Terminators and 4.5 ml of
distilled deionized water. The BigDye XTerminator
Purification Kit (Applied Biosystems) was used to eliminate
unincorporated dye terminators and free salts by adding
20 ml of the SAMTM solution and 5 ml of the XTerminatorTM
to each of the 10 ml sequencing reactions. The mixture was
placed on a shaker at full speed for 30 min and then centri-
fuged at 1000 rpm for 2min. Samples were run on the 3130xl
automated DNA sequencer (Applied Biosystems). Sequencing
data were analysed using the CodonCode Aligner v.4.2.4
(CodonCode Corp., USA) and Finch TV (GeoSpiza, Seattle,
WA). Wild-type sequence was derived from the Ensembl
Genome Browser (Wellcome Trust Sanger Institute,
Cambridge, UK).
Derivation of human fibroblast cell
lines from skin biopsies
Skin biopsies were directly placed in 10ml of transport media
[Hams F10 (Sigma) supplemented with amoxicillin (100 mg/
ml)] and transported at room temperature. Individual samples
were transferred to a sterile 35 or 60mm Petri dish. The epi-
dermis layer with hair, if present, was removed using sterile
forceps and scalpel, leaving only the dermis layer. Fatty tissue
and fat globules were also removed. The tissue sample was
rinsed with transport media. A 5–10 mm2 piece of the cleaned
sample was disassociated either with forceps and scalpel, or
wide-bore syringe and needle, and transferred to a fresh
35mm Petri dish. The tissue was covered with collagenase
solution and placed in a 37C incubator for at least 30min.
After removing the collagenase with a sterile Pasteur pipette,
the tissue was covered with Trypsin EDTA/Hank’s balanced
salt solution and incubated at 37C for a further 10–15min.
The solution containing the cell suspension was gently mixed,
transferred to a centrifuge tube and centrifuged at 1800 rpm
for 8min. After removing the supernatant, 6ml of F10 media
was added and the sample gently resuspended. The sample was
split between two cell culture flasks and transferred to a 37C
incubator. Fibroblast cultures were propagated in Hams F10
media (Sigma) or GIBCO AmnioMAX
TM
Basal Medium
(450ml) with GIBCO AmnioMAX
TM
C100 supplement
(75ml), newborn calf serum (Sigma), L-glutamine and amoxi-
cillin (0.5ml).
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Derivation of EBV lymphoblastoid
cell lines from whole blood
Whole blood taken by venous puncture and collected in ACD-
B tubes was shipped on ice. After spinning, lymphocytes were
collected and transformed as previously described by Public
Health England (https://www.phe-culturecollections.org.uk/ser-
vices/hgs/ebvtransformation.aspx).
Exponentially growing cell lines were transported in T25
flasks as growing cultures. Lymphoblastoid cell lines were pro-
pagated in RPMI1640 media (Sigma) with glutamine (2mM)
and foetal bovine serum added.
Site-directed mutagenesis
Site-directed mutagenesis was performed using QuikChange
Multi Site-Directed Kit (Agilent Technologies) according to the
manufacturer’s protocol. The mutagenic primer
(50-GAGTAAAGAGGTGCGcGAGCATCTGCTCC-30) was
designed according to guidance in the QuikChange manual
and was used to introduce a valine to methionine mutation at
position 231 of human WIPI2b in GFP pEGFP-C1-WIPI2b.
Transfection
HEK293A cells were transfected with the plasmids indicated in
figure legends using Lipofectamine 2000 (Life Technologies).
Cells were plated to be 80% confluent on the day of transfec-
tion. Transfection mixture was made up of 1 mg plasmid DNA
and 6 ml Lipofectamine 2000 in 1ml of Opti-MEM
TM
(Life
Technologies).
Immunoprecipitation
Overexpressed GFP-tagged proteins were immunoprecipitated
using GFP-TRAP beads (ChromoTek). Transfected cells were
washed with PBS and then lysed in 10mM Tris HCl pH 7.5,
150mM NaCl, 0.5mM EDTA, 0.5% NP-40, 1 complete
protease inhibitor (Roche). Lysates were clarified at
13 000 rpm at 4C, and the lysate was diluted to 0.25% NP-
40. The lysate was pre-cleared with blocked agarose bead
slurry (ChromoTek) before incubating with GFP-TRAP beads
(ChromoTek) at 4C for 1 h. Immunoprecipitates were washed
three times with 10mM Tris HCl pH 7.5, 150mM NaCl,
0.5mM EDTA, 1% NP-40, 1 complete protease inhibitor.
Protein complexes were eluted with 2 Laemmli sample
buffer at 65 C for 10min.
For immunoprecipitation of endogenous WIPI2, cells were
pretreated with dithiobis(succinimidyl propionate)/Lomat’s re-
agent (DPS) (Thermo Scientific) at 0.5mM in PBS for 30min
on ice. Cells were lysed in 1% Triton TNTE (1% Triton
TM
X-
100, 20mM Tris HCl pH 7.5, 150mM NaCl, 5mM EDTA)
supplemented with 1 protease inhibitor cocktail and the
lysate clarified by centrifuging at 13 000 rpm at 4C.
Clarified lysate was incubated with monoclonal WIPI2 antibo-
dies (antibody 2A2), at 4C overnight before being added to
washed protein G beads (Sigma) and incubated for another 2 h
at 4 C. The beads were pelleted (1000 rpm, 4C for 1min)
and were washed four times in 1% Triton
TM
X-100 TNTE
buffer. Protein complexes were eluted and DPS crosslinks
were cleaved by boiling the washed bead pellets at 100C, in
50 ml of 2 Laemmli sample buffer with 50mM dithiothreitol
(DTT), for 10min.
SDS-PAGE and western blotting
SDS-PAGE was performed using NuPAGE 4–12% Bis-Tris
precast protein gels (Life Technologies). Proteins were trans-
ferred to polyvinylidene fluoride (PDVF) membrane (Millipore)
using wet transfer. For western blotting, PDVF membranes
were blocked with 5% powder milk (w/v) (Marvel) and 0.1
% PBS-tween before incubation with antibodies as indicated in
Figures [GFP (Abcam); WIPI2 (2A2, Polson et al. 2010)].
HRP-conjugated secondary antibodies (GE Healthcare) and
ECL (Amersham, GE Healthcare) were used for protein band
visualization. 0.1% PBS-tween was used for washing between
antibody incubations.
Immunofluorescence
Cells were cultured on coverslips for 24 h, and fixed in 3%
paraformaldehyde for 20min. Cells were permeabilized with
methanol at room temperature for 5min and blocked for 1 h
in 5% bovine serum albumin (BSA) (Roche), before staining
with WIPI2 (2A2, Dundee Cell Products) and LC3 (Abcam)
primary antibodies in 1% BSA for 1 h. Cells were washed
three times in PBS and stained with secondary antibodies
Alexa Fluor 488 (Thermo) and 555 (Thermo) in 1% BSA
for 1 h. Cells were then washed three times in PBS and once
in water. WIPI2 and LC3 puncta were analysed by Imaris
image analysis software.
Data availability
The authors are happy to share all of the data reported here.
Results
Clinical investigations of a novel
developmental phenotype
We identified an extended pedigree with a complex devel-
opmental disorder involving mental retardation, speech and
language impairment (both receptive and expressive lan-
guage were affected), cardiac, neurological, thyroid and
skeletal abnormalities (Fig. 1). Detailed clinical studies of
two affected members of the family (Patients NA and AA),
aged 43 and 45, respectively, from two separate branches
of the family, were carried out. There were no reported
complications of pregnancy in either case, and their birth
weights were reported to be normal. Overall, Patient NA
appeared to be more affected clinically. One member of the
first branch of the family (Patient SG), the brother of
Patient NA, died aged 48 years old and was reported to
have dysphagia. The affected males from this branch of the
family did not marry, but the unaffected brother and the
two unaffected sisters are married, producing phenotypic-
ally normal offspring.
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Primarily, the disease manifests as severe mental retard-
ation. The IQ of patients is significantly low and develop-
mental milestones were reported to be significantly delayed.
CT scans show mild, but more than expected for the age,
global brain volume loss and prominence of the ventricles
(Fig. 2). Significant delays were observed in fine/gross
motor activities suggestive of a cerebellar dysfunction.
Another peculiar finding is short stature in comparison to
the rest of the family members and the local population in
general. One of the study patients (Patient NA) has mildly
increased thoracic kyphosis, mild bilateral thumb hypopla-
sia, bilateral mild clinodactyly of the little fingers and
bilateral overlapping fifth toes (Fig. 2). He also has wide-
based gait with short steps. Patient AA has bilateral camp-
todactyly of the little fingers rather than clinodactyly.
Additionally, late onset lumbar vertebrae abnormalities
were reported in two members of the extended family
(not represented in Fig. 1) that were not age related.
Cardiac abnormalities were also observed on ECG, but
did not appear to be clinically relevant. In Patient NA,
sinus rhythm P waves appear peaked, with incomplete
right bundle branch block and short PR interval and
there appear to be delta waves. In Patient AA, sinus
rhythm P waves also appear peaked, and interventricular
conduction delay is similar to Patient IV-4 but less pro-
nounced, with slurring of R wave in chest leads, but no
delta wave. Echocardiography does not suggest any major
structural or haemodynamic derangement. Both the study
subjects (Patients NA and AA) have subclinical hypothy-
roidism (normal T3/T4; raised thyroid stimulating
hormone).
Genetic studies to screen for
structural variants and point
mutations
To investigate a possible involvement of chromosomal ab-
errations and for the purpose of homozygosity mapping,
microarray analysis was performed with a
HumanCytoSNP-12 v12.1 chip (Illumina) on nine family
members, including four affected individuals from two sep-
arate branches of the extended pedigree (Fig. 1). We carried
out loss of heterozygosity analysis and identified a single
region of homozygosity shared amongst all four affected
individuals, a 2.5Mb region on chromosome 7p22 (pos-
itions 3059377–5478971) spanning 31 genes.
Exome sequencing was performed on Patients NA and
AA. Screening for non-synonymous homozygous or com-
pound heterozygous variants and stop codons within the
region of homozygosity on chromosome 7 identified by the
SNP array (see ‘Materials and methods’ section), resulted in
a single gene. We identified a novel homozygous mutation
in exon 9 (c.G745A;pV249M) in the WD-repeat protein
interacting with phosphoinositide 2 gene (WIPI2), at gen-
omic base position 5265458 (Fig. 3A). The mutation affects
multiple isoforms and is predicted to be damaging
according to the PolyPhen-2 software, with a maximum
score of 1.000. The V249 residue is highly conserved
across species (Fig. 3B) and is also present in WIPI1, a
member of the WIPI gene family (Polson et al., 2011).
The mutation is located at the start of blade 6 (Fig. 3C),
near the site implicated in PI(3)P and PI(3,5)P2 binding,
defined as site 2 (Baskaran et al., 2012; Krick et al.,
2012; Watanabe et al., 2012) and is C-terminal to the
highly conserved residues involved in PI(3)P binding,
including the arginine (R) at position 243 (Fig. 3E).
The mutation, was confirmed by Sanger sequencing
(Fig. 3D) in 10 family members from two separate
branches of the extended pedigree (Fig. 1). As expected, it
segregates correctly with the disease phenotype consistent
with an autosomal recessive pattern of inheritance.
Ethnically matched controls (n = 217) were screened to ex-
clude any possible population-specific common polymorph-
isms. Furthermore, the mutation is absent in the
homozygous state in all publically available genomic data-
bases including exome variant server (http://evs.gs.washing-
ton.edu/EVS), ExAC (http://exac.broadinstitute.org/) and
Greater Middle East (GME) Variome databases (http://
igm.ucsd.edu/gme/index.php). ExAC alone represents data
from over 60 000 genomes from different ancestries, includ-
ing African, European, Latino and Asian with the GME
databases representing 2497 exomes. The V249M mutation
is listed in ExAC, athough it is found in only one allele of
88 940.
Effect of V249M mutation on
formation of autophagosomes
WIPI2b is required for formation of autophagosomes and
for LC3 lipidation (Dooley et al., 2015). We examined
fibroblast cells derived from a patient (Patient AA) and
an unaffected family member (Subject RG) to determine if
the formation of autophagosomes was altered. WIPI2 and
LC3 are cytosolic proteins that are recruited to autophago-
somes upon induction of autophagy by amino acid starva-
tion. The recruitment of these proteins is visualized by the
formation of punctate structures on the phagophore and
the autophagosome (Polson et al., 2010). We incubated
fibroblasts from control and patient cells in complete
growth medium (fed) or medium lacking amino acids to
induce autophagy (starved). As seen in Fig. 4A, LC3 and
WIPI2 puncta were formed in starved control cells (Subject
RG) as expected. In contrast, in starved patient cells
(Patient AA) there appeared to be weakly stained, smaller
LC3 puncta; however, there were virtually no WIPI2
puncta detectable. Quantification of the control fed versus
control starved cells revealed WIPI2 puncta increased by
410-fold and there was at least a 30–40-fold increase in
LC3 puncta (Fig. 4B and C). In contrast, in the patient
fibroblasts the number of WIPI2 puncta was significantly
decreased to 54-fold (compare Subject RG starved
medium versus Patient AA starved medium). The absence
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of WIPI2 puncta supports the possibility that the VM mu-
tation in WIPI2 alters the association of WIPI2 with PI(3)P
and thus the membrane.
Next, we tested levels of autophagy flux in basal and
amino acid starvation in the human fibroblasts by inhibit-
ing the lysosomal degradation with the lysosomal inhibitor
Bafilomycin A1 (BafA1). This allows the measurement of
productive autophagy as a result of autophagosome forma-
tion and fusion with the lysosome. In this experimental
setting it is important to note only sequestered cargo
(LC3, other cytosolic proteins and organelles), which are
inside the autophagosome, will be degraded and thus af-
fected (increased) by BafA1 treatment. Therefore, we exam-
ined autophagic flux by the addition of 100 nM BafA1 to
cells either in complete medium or cells incubated in amino
acid free starvation medium and measured LC3 puncta. As
seen in Fig. 4C, in patient cells comparing the LC3 puncta
in fed medium with the LC3 puncta accumulating in the
presence of BafA1 (complete medium basal flux) we see a
significant increase. This is not altered by incubation in
starvation (compare Patient AA complete medium with
starvation medium). However, LC3 puncta were increased
upon starvation in the presence of BafA1 (starvation
medium) compared to starvation alone, although the total
response in Patient AA fibroblasts (starvation medium) was
significantly less than the control Subject RG fibroblasts
(starvation medium). This suggests the patient fibroblasts
have an altered starvation response.
Effect of V249M mutation on WIPI2
function
We performed functional studies to assess the effect of the
mutation in WIPI2 on binding to ATG16L1. Previously,
using HEK293A cells expressing GFP-WIPI2b, we showed
using GFP pull-downs that ATG16L1 binds to WIPI2b at
amino acid residues Arg108 and Arg125. This binding be-
tween WIPI2b and ATG16L1 directs lipidation of LC3 to
the autophagosome membrane, where it localizes to puncta
(Dooley et al., 2014) as shown in Fig. 4. Therefore, to test
the effect of the V249M mutation on ATG16L1 binding,
we mutated valine in position 231 in GFP-WIPI2b (corres-
ponding to V249 in the canonical isoform1 of WIPI2a) to a
methionine to phenocopy the patients’ mutation.
HEK293A cells were transfected with either GFP-WIPI2b
wild-type or GFP-WIPI2b V231M. As seen in Fig. 5A, GFP-
WIPI2b V231M showed reduced binding to ATG16L1 com-
pared to the GFP-WIPI2b wild-type. This result suggests that
the mutation in V231 reduced the interaction of GFP-
WIPI2b with ATG16L1. Given that the V231 mutation in
WIPI2b is located near the PI(3)P binding site, and not the
ATG16L1 binding site, this result was unexpected.
Figure 2 Skeletal and neurological abnormalities in patients. (A–C) Patient AA, aged 43 years, and Patient NA (D–I), aged 45 years,
show a range of clinical abnormalities, including clinodactyly, overlapping of fifth toes, increased thoracic kyphosis, thumb hypoplasia and enlarged
ventricles in the brain.
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Therefore, we examined the interaction of endogenous
WIPI2 with endogenous ATG16L1 using a crosslinking
approach followed by immunoprecipitation, which we
developed previously (Dooley et al., 2014). We used lym-
phoblastoid cell lines from the control (Subject RG) or the
affected patient (Patient AA). To ensure that the WIPI2
V231M mutant protein was stable in these cells we blotted
Subject RG and Patient AA cells with antibodies to WIPI2,
ATG16L1 and FIP200. As seen in Fig. 5B, WIPI2 and
ATG16L1 proteins appeared to be stably expressed in
Patient AA cells compared to Subject RG control cells.
The levels of other ATG proteins involved in the associ-
ation of ATG16L1 to the autophagosome, such as FIP200
(a member of the ULK1 complex), were unchanged in the
patient cells compared to control cells.
Next, following treatment of the cells with crosslinkers at
4C and lysis, we used an antibody to WIPI2, which rec-
ognizes four isoforms of WIPI2(a–d), to immunoprecipitate
the crosslinked complex. As shown in Fig. 5C, we were
able to immunoprecipitate endogenous ATG16L1 with
endogenous WIPI2, but there was no difference in the inter-
action in Patient AA control cells compared to Subject RG
patient cells.
The result in Fig. 5C contrasts with the GFP-WIPI2b
V231M mutant in Fig. 5A where the V231M mutant is
unable to bind ATG16L1. It may be that the V to M
Figure 3 Genomic structure and mutation inWIPI2 gene. (A) The exon-intron structure of the WIPI2 gene is depicted, highlighting the
pV249M mutation. (B) Phylogenetic analysis demonstrates the cG745A mutation is in a region that is highly conserved across multiple species.
(C) Model of WIPI2 (Wilson et al., 2014) based on the structure of Hsv2 (Baskaran et al., 2012). WIPI2 is a 7-bladed propeller protein capable of
interacting with PI(3)P and PI(3,5)P2 at sites 1 and 2. The WIPI2 pV249M mutation resides within site 2 in blade 6. (D) Sanger sequencing confirms
the cG745A mutation correctly segregates with the phenotype in 10 family members (Fig. 1). Representative sequence traces from affected (/),
unaffected ( + /) and control ( + / + ) individuals are presented, corresponding to genotypes AA, AG and GG, respectively. (E) Sequence
alignment of PROPPIN family members. The boxed region highlights the position of the pV249M residue and its comparison across PROPPIN
family members. Figure adapted from Baskaran et al. (2012). Residues involved in binding PI(3)P and PI(3,5)P2, including R243, which is an essential
requirement for binding to occur, are highlighted in yellow.
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mutation at position 231 causes a conformational change
in the GFP-WIPI2b, which reduces ATG16L1 binding.
Alternatively, the V231M mutation may cause a reduction
in the affinity of WIPI2b to ATG16L1, which is revealed
upon overexpression of GFP-WIPI2b V231M, but not
under endogenous conditions, in particular because we
cannot identify the WIPI2b isoform in endogenous immu-
noprecipiation. The transient overexpression of GFP-
WIPI2b wild-type and/or GFP-WIPI2b V231M mutant
upon transfection will bind the ATG16L1 existing in the
cell, possibly displacing the endogenous protein, and this
binding or competition may be weaker upon mutation of
V231M. In contrast, in the control and patient cells it may
be that the endogenous WIPI2 proteins are present in com-
plexes, for example with ATG16L1, formed over hours or
days. The V to M mutant may have a weaker binding
affinity but once bound to ATG16L1 appears to be similar
to the normal WIPI2 protein.
Discussion
We identified a mutation in the majorWIPI2 gene (pV249M)
in an extended family with a complex developmental disorder.
Thismutation resides in the flexible loop between blades 5 and
6, crucially, adjacent to the previously reported PI(3)P and
PI(3,5)P2 binding site (site 2) in blade 6 of the propeller
(Baskaran et al., 2012; Krick et al., 2012; Watanabe et al.,
2012). The key residues previously described in this inter-
action, including the highly conserved residue R243, flank
the mutation. Site directed mutagenesis of R243, abolishes
both PI(3)P and PI(3,5)P2 binding (Baskaran et al., 2012;
Krick et al., 2012; Watanabe et al., 2012). The ATG16L1
Figure 4 WIPI2 puncta formation is inhibited in human fibroblasts isolated from patients carrying a WIPI2 mutation. (A)
Control (RG) and mutant (AA) human fibroblasts were incubated in either full medium (FM), or treated with 100 nM Bafilomycin A1 in full-
nutrient medium (FB), or amino acid starvation medium (SM), or 100 nM Bafilomycin A1 in starvation medium (SB) for 2 h and then fixed. Cells
were stained with antibodies against WIPI2 and LC3. Scale bar = 10 mm. (B and C) WIPI2 and LC3 puncta were quantified in 10 fields per
condition. Statistical analysis was performed by one-way ANOVA with Tukey’s post-test. ****P5 0.0001.
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binding site ofWIPI2b is located in the basic cleft between the
WD propeller blades 2 and 3 specifically defined by arginine
residues R108 and R125, which bind an acidic region of
ATG16L1, seemingly at a distance from the mutation in
blade 6, but theC-terminal domain ofWIPI2b is also thought
to be involved in modulating the binding (Dooley et al.,
2014).
Four members of WIPI family of proteins (WIPI1–WIPI4)
have been described. Classified as seven- bladed b-propeller
proteins that bind phosphatidylinositols (PROPPINs) (Dove
et al., 2004), they bind specifically phosphatidylinositol 3-
phosphate PI(3)P and phosphatidylinositol 3,5-bispho-
sphate [PI(3,5)P2] and appear to have overlapping roles
(Jeffries et al., 2004; Proikas-Cezanne et al., 2004; Polson
et al. 2010; Dooley et al., 2014; Bakula et al., 2017).
WIPI1, WIPI2 and WIPI4 are capable of interacting with
each other and share a common interacting partner, NudC
(Bakula et al., 2017), although WIPI3 and WIPI4 appear to
have a role in pathways both upstream of PI(3)P produc-
tion but also potentially downstream of LC3 lipidation
(Bakula et al., 2017) with WIPI4 potentially involved in
the recruitment of ATG2A and B downstream to WIPI2
(Velikkakath et al., 2012).
WIPI2 shares the highest homology with WIPI1 and the
V249 residue mutated in our patients is conserved in WIPI1
(Fig. 3E). Whilst WIPI1 plays a supporting role in facilitat-
ing the recruitment of ATG16L1 complex for LC3 lipida-
tion by WIPI2 and can associate with ATG16L1, although
to a lesser extent than WIPI2 (Bakula et al., 2017), WIPI2
plays a role in localization of WIPI1 to nascent autophago-
somes (Bakula et al., 2017).
WIPI2 itself exists as five isoforms (a–e), four of which are
characterized. WIPI2b and d are recruited to the membrane
upon PI(3)P production by the class III PI3 kinase complex
containing Beclin 1 and ATG14 (Mauthe et al., 2011;
Dooley et al., 2014). The role of WIPI2b in autophagy
begins with recruitment of WIPI2b to the nascent autophago-
some in response to PI(3)P production at the endoplasmic re-
ticulum. Production of PI(3)P is initiated by upstream proteins,
including VPS34. Recruitment of WIPI2b is followed by
the recruitment of the ATG12–5–16L1 complex, to en-
able conjugation of LC3 conjugation to membrane
Figure 5 Analysis of WIPI2 interaction with ATG16L1. (A) GFP-WIPI2b WT or GFP-WIPI2b V231M were transiently expressed in
HEK293A cells. The cells were lysed and subjected to immunoprecipitation using GFP-TRAP beads. ATG16L1, ATG12 and GFP (alone or GFP-
WIPI2b), in the input, unbound and bound to the GFP-TRAP beads, were detected using the specific antibodies against ATG16L1, ATG12 and GFP.
Note data are from same western blot but shown in pieces to aid interpretation. (B) Total cell lysate from the unaffected control (RG) and the
patient (AA) were analysed for levels of FIP200, ATG16L1 and WIPI2. (C) Cell lysates from the control (RG) or the patient (AA) were prepared
after the treatment of the respective cell lines with a crosslinker on ice. WIPI2 was immunoprecipitated with an antibody against WIPI2, and the
input, unbound and immunoprecipitates were analysed by western blot, using antibodies against ATG16L1 and WIPI2. The WIPI2 immunopre-
cipitation was done with antibody plus protein A beads (beads + Ab) or antibody alone (Ab).
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phosphatidylethanolamine (PE) and lipidation (reviewed by
Mu¨ller and Proikas-Cezanne, 2015). Our experiments suggest
binding ofWIPI2b toATG16L1 (andATG12-ATG5)might be
altered in patient cells studied here. In addition, the patient cells
have virtually no WIPI2 puncta, suggesting the recruitment of
WIPI2 to the phagophore and autophagosome is altered. We
also observe an alteration of LC3 puncta intensity and size and
an altered response to starvation stimuli. Basal flux, whichmay
be more relevant for the patient phenotype, appears to be
increased but the consequences of this has not been explored.
De novo mutations in the WIPI4 gene have been identi-
fied in five patients with SENDA (static encephalopathy of
childhood with neurodegeneration in adulthood), an
X-linked neurodegenerative disorder associated with child-
hood psychomotor retardation, sudden onset progressive
dystonia-parkinsonism and dementia, plus iron deposition
in the globus pallidus and substantia nigra (Saitsu et al.,
2013; Seibler et al., 2018). In addition to the severe psy-
chomotor developmental delay from infancy and severe in-
tellectual disability, the patients become bedridden within a
few years of the cognitive decline. The phenotype observed
in our patients is associated with less severe neurological
symptoms, considering the patients described by Saitsu
et al. (2013) were mostly bedridden or in a wheelchair.
However, the mutations in WIPI4 mainly involve protein
truncations as well as in-frame and frame-shift insertions,
resulting in severely reduced protein expression and appear
to be lethal in males. By contrast, we identified a missense
mutation and levels of WIPI2 protein expression do not
appear to be significantly altered in our patients.
In addition to what we have described, additional clinical
signs have been observed in our patients, including signs of
ageing, dental enamel eruptions, cataracts and rough and
brittle hair. Both of the patients we assessed are reported
to have bruxism (teeth grinding), which appears to have
caused severe deformities of the teeth. This has previously
been reported to occur with lesions of the basal ganglia (Tan
et al., 2004). Interestingly, there is a family history of tuber-
culosis, which has also been linked to autophagy (Castillo
et al., 2012; Kimmey et al., 2015). Linking these broader
clinical observations with the WIPI2 pathway in the cell,
should add to the growing evidence linking autophagy
with both normal development and disease processes.
Untangling WIPI2 from the overlapping roles of other
WIPI family members will no doubt further illuminate this
pathway. In addition, alternate pathways involving other
proteins including FIP200, which can bind, and possibly re-
cruit, the ATG12–5–16L1 complex to sites of autophago-
some as well as the PI(5)P pathway that is independent of
PI(3)P (Gammoh et al., 2013; Vicinanza et al., 2015;
Vicinanza and Rubinsztein, 2016) might also play an im-
portant role.
The precise mechanisms of autophagy are complex and
presently unclear. The serendipitous identification of a
naturally occurring mutation in WIPI2 (within the critical
PI(3)P/PI(3,5)P2 binding domain) that leads to fewer
autophagosomes in cells derived from patients, should
shed further light on the complex mechanisms leading to
the mature autophagosome.
Web resources
Exome Variant Server. NHLBI Exome sequencing Project
(ESP). http://evs.gs.washington.edu/EVS/ 2012.
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